OnCusp Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- OnCusp Therapeutics's estimated annual revenue is currently $4.8M per year.
- OnCusp Therapeutics's estimated revenue per employee is $201,000
- OnCusp Therapeutics's total funding is $139M.
Employee Data
- OnCusp Therapeutics has 24 Employees.
- OnCusp Therapeutics grew their employee count by 0% last year.
OnCusp Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, Chairman, and CEO | Reveal Email/Phone |
2 | Co-Founder, Chief Development Officer, Head Research and Development | Reveal Email/Phone |
3 | Co-Founder, Chief Business Officer | Reveal Email/Phone |
4 | Head Translational Medicine (Consulting/Remote) | Reveal Email/Phone |
5 | VP Clinical Development | Reveal Email/Phone |
6 | VP, Technical Operations | Reveal Email/Phone |
7 | VP, Research | Reveal Email/Phone |
8 | Senior Director Project Management | Reveal Email/Phone |
9 | Senior Manager Human Resources Operations | Reveal Email/Phone |
10 | Clinical Operations Manager | Reveal Email/Phone |
OnCusp Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.1M | 65 | 7% | N/A | N/A |
#2 | $354.3M | 484 | -2% | $567.1M | N/A |
#3 | $347.1M | 1727 | -8% | N/A | N/A |
#4 | $8.8M | 44 | 13% | N/A | N/A |
#5 | $6M | 30 | 11% | N/A | N/A |
#6 | $46.6M | 232 | 4% | N/A | N/A |
#7 | $6.6M | 33 | -3% | N/A | N/A |
#8 | $11.3M | 56 | 12% | N/A | N/A |
#9 | $168.8M | 840 | 46% | N/A | N/A |
#10 | $12.3M | 61 | -21% | N/A | N/A |
What Is OnCusp Therapeutics?
OnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide. OnCusp was co-founded by Dr. Bing Yuan, Dr. Eric Slosberg, and Dr. Andy Fu, and has built a strong team of accomplished veterans with proven track records in building startup biotechs, leading successful preclinical and clinical programs, and creating value through global partnerships. The company is committed to accelerating the advancement of globally competitive oncology assets for patients.
keywords:N/A
$139M
Total Funding
24
Number of Employees
$4.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.8M | 24 | 4% | N/A |
#2 | $1.7M | 24 | -8% | $19.7M |
#3 | $3.8M | 24 | -11% | N/A |
#4 | $2.4M | 24 | N/A | N/A |
#5 | $3.5M | 24 | N/A | N/A |